Novel Psychoactive Substances: What Educators Need to Know

被引：9

作者：

Patterson, Z. R. ^{[1
]}

Young, M. M. ^{[1
,2
]}

Vaccarino, F. J. ^{[3
]}

机构：

[1] Canadian Ctr Subst Abuse, Ottawa, ON, Canada

[2] Carleton Univ, Dept Psychol, Ottawa, ON, Canada

[3] Univ Guelph, Guelph, ON, Canada

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2017年 / 101卷 / 02期

关键词：

D O I：

10.1002/cpt.538

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Novel psychoactive substances (NPS) are synthetic, psychoactive drugs that are generally not under international regulatory control. NPS are frequently sold as alternatives to classic "street drugs" such as ecstasy or LSD. However, little is known about their pharmacology and toxicity and they therefore pose unknown health risks. Further, risk for harms are elevated because users often do not know what they are taking, and therefore cannot predict dose, potency, or other potential properties.

引用

页码：173 / 175

页数：3

共 4 条

[1] Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications [J].

Castaneto, Marisol S. ;

Gorelick, David A. ;

Desrosiers, Nathalie A. ;

Hartman, Rebecca L. ;

Pirard, Sandrine ;

Huestis, Marilyn A. .

DRUG AND ALCOHOL DEPENDENCE, 2014, 144 :12-41

[2]

EMCDDA, 2014, 9781782464624 EMCDDA

[3]

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2016, HLTH RESP NEW PSYCH

[4] Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signalling [J].

Liechti, Matthias E. .

SWISS MEDICAL WEEKLY, 2015, 145

← 1 →